Other targets of NCT04550481 are steatosis, CAP, NAFLD fibrosis score (NFS), and inflammatory markers such as caspase cleaved CK-18, NF-kB, TGF-b, TNF-a, IL6, and IL8. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.